Endoways
Self-propelling Microcatheter for Tortuous Blood Vessels
Company Overview
Snapshot
Founded in February 2018 by Tamir Ben David and Noam Shamay, Endoways operates with 1-10 employees. The company was acquired by Ascendum Capital in February 2021, marking a significant exit for the medical device innovator.
Business overview
Endoways specializes in medical technology, developing a robotic microcatheter designed for advanced self-propulsion through tortuous blood vessels. This technology aims to enhance the ability of interventional radiologists to navigate complex anatomies, thereby simplifying procedures, reducing overall procedure time, and minimizing radiation exposure for both patients and medical staff. The company operates within the Health Tech & Life Sciences sector, serving clinics, hospitals, and surgeons with its innovative surgical instruments and robotics.
Strategic signal
In February 2021, Endoways was acquired by Hong Kong-based investment platform Ascendum Capital. This acquisition is a strong validation of Endoways' robotic microcatheter technology and is expected to accelerate its clinical and commercial development, particularly in the Chinese market. For investors, this signals the strategic value of advanced medical robotics in simplifying complex procedures and improving patient outcomes, with a clear pathway for global market expansion.
Log in to access full profile ›Company Intelligence Q&A
- What was the most significant corporate event for Endoways?
- In February 2021, Endoways was acquired by Ascendum Capital. This acquisition is expected to accelerate the company's clinical and commercial development, especially in China.
- Who founded Endoways?
- Endoways was founded by Tamir Ben David and Noam Shamay in February 2018.
- What is Endoways' core technology?
- Endoways has developed a robotic microcatheter with advanced self-propulsion capabilities, designed to navigate through tortuous blood vessels more efficiently.
- What problem does Endoways' technology address?
- The Endoways microcatheter aims to provide interventional radiologists with a superior ability to cross tortuous anatomy, simplifying complex procedures, shortening overall procedure time, and minimizing radiation exposure for patients and medical staff.
- Which investors participated in Endoways' funding round?
- In March 2018, Endoways received funding from Israel Innovation Authority and MEDX Xelerator.